IN192220B - - Google Patents

Info

Publication number
IN192220B
IN192220B IN419CA2001A IN192220B IN 192220 B IN192220 B IN 192220B IN 419CA2001 A IN419CA2001 A IN 419CA2001A IN 192220 B IN192220 B IN 192220B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
James Harrison Pickar
Barry Samuel Komm
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22151320&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN192220(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by American Home Prod filed Critical American Home Prod
Publication of IN192220B publication Critical patent/IN192220B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IN419CA2001 1998-05-15 2001-07-31 IN192220B (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7956198A 1998-05-15 1998-05-15

Publications (1)

Publication Number Publication Date
IN192220B true IN192220B (enExample) 2004-03-20

Family

ID=22151320

Family Applications (1)

Application Number Title Priority Date Filing Date
IN419CA2001 IN192220B (enExample) 1998-05-15 2001-07-31

Country Status (41)

Country Link
EP (1) EP1076558B1 (enExample)
JP (3) JP2002515431A (enExample)
KR (1) KR100620772B1 (enExample)
CN (1) CN1230163C (enExample)
AP (1) AP1424A (enExample)
AR (1) AR020074A1 (enExample)
AT (1) ATE245026T1 (enExample)
AU (1) AU760378B2 (enExample)
BE (1) BE2015C026I2 (enExample)
BG (1) BG64783B1 (enExample)
BR (1) BR9911040A (enExample)
CA (1) CA2329530A1 (enExample)
CU (1) CU23241B7 (enExample)
CY (1) CY2015020I1 (enExample)
CZ (1) CZ299334B6 (enExample)
DE (1) DE69909616T2 (enExample)
DK (1) DK1076558T3 (enExample)
EA (1) EA005932B1 (enExample)
EE (1) EE04262B1 (enExample)
ES (1) ES2203131T3 (enExample)
FR (1) FR15C0035I2 (enExample)
GE (1) GEP20033079B (enExample)
HR (1) HRP20000778B1 (enExample)
HU (2) HU226587B1 (enExample)
ID (1) ID26890A (enExample)
IL (1) IL139130A (enExample)
IN (1) IN192220B (enExample)
LT (1) LTC1076558I2 (enExample)
LU (1) LU92699I2 (enExample)
NO (2) NO328129B1 (enExample)
NZ (1) NZ508200A (enExample)
OA (1) OA11552A (enExample)
PL (1) PL194750B1 (enExample)
PT (1) PT1076558E (enExample)
SI (1) SI1076558T1 (enExample)
SK (1) SK284666B6 (enExample)
TR (1) TR200003377T2 (enExample)
TW (1) TW565554B (enExample)
UA (1) UA66861C2 (enExample)
WO (1) WO1999059581A1 (enExample)
ZA (1) ZA200006959B (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP1424A (en) * 1998-05-15 2005-06-06 Wyeth Corp 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens.
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
JP4790178B2 (ja) 1999-07-06 2011-10-12 アンドルシェルシュ・インコーポレイテッド 体重増加の処置方法および／または抑制方法
US20020013327A1 (en) * 2000-04-18 2002-01-31 Lee Andrew G. Compositions and methods for treating female sexual dysfunction
AU2001273125A1 (en) * 2000-07-06 2002-01-21 American Home Products Corporation Combinations of bisphosphonates, estrogenic agents and optionally estrogens
AU2001271784A1 (en) * 2000-07-06 2002-01-21 Wyeth Therapy for prosthesis-related bone degeneration
US6376486B1 (en) 2000-07-06 2002-04-23 American Home Products Corporation Methods of inhibiting sphincter incontinence
US6455568B2 (en) 2000-07-06 2002-09-24 Wyeth Combination therapy for inhibiting sphincter incontinence
WO2002003989A2 (en) * 2000-07-06 2002-01-17 Wyeth Use of substituted indole compounds for treating sphincter incontinence
EP1359940A2 (en) * 2000-07-06 2003-11-12 Wyeth Combinations of statins, estrogenic agents and optionally estrogens
DE10117441A1 (de) * 2001-04-03 2002-10-10 Schering Ag 1-Indolylderivate, deren Verwendung zur Herstellung von Arzneimitteln, ein Verfahren zur Herstellung der 1-Indolylderivate sowie 1-Indolylderivate enthaltende pharmzeutische Präparate
CN1599606A (zh) 2001-07-31 2005-03-23 辉瑞产品公司 包含雌激素激动剂/拮抗剂、雌激素与孕激素组合的药物组合物、试剂盒和方法
KR100470274B1 (ko) 2002-11-08 2005-02-05 진 장 덮개층을 이용한 비정질 물질의 상 변화 방법
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
FR2880625B1 (fr) * 2005-01-07 2007-03-09 Sanofi Aventis Sa Derives de n-(heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
RS54165B1 (sr) 2008-04-16 2015-12-31 Karo Bio Ab Novi ligandi za estrogenski receptor
AR072297A1 (es) * 2008-06-27 2010-08-18 Novartis Ag Derivados de indol-2-il-piridin-3-ilo, composicion farmaceutica que los comprende y su uso en medicamentos para el tratamiento de enfermedades mediadas por la sintasa aldosterona.
GB201113538D0 (en) 2011-08-04 2011-09-21 Karobio Ab Novel estrogen receptor ligands
CN102690225B (zh) * 2012-04-11 2014-12-24 南京友杰医药科技有限公司 巴多昔芬的合成方法
CN103709090A (zh) * 2014-01-16 2014-04-09 江苏万特制药有限公司 醋酸巴多昔芬的制备方法及其关键中间体
CN103739540B (zh) * 2014-01-20 2016-05-04 华润赛科药业有限责任公司 一种醋酸巴多昔芬中间体的制备方法
CN105669518B (zh) * 2014-12-04 2019-06-04 上海医药集团股份有限公司 醋酸巴多昔芬及其a晶型的制备方法
US12030878B2 (en) * 2017-12-15 2024-07-09 Bristol-Myers Squibb Company Substituted indole ether compounds
IT201800006562A1 (it) * 2018-06-21 2019-12-21 Procedimento e intermedi utili per la preparazione di indoli
CN115380026B (zh) * 2020-03-17 2023-11-07 南京明德新药研发有限公司 蛋白降解调节剂与其使用方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4729999A (en) * 1984-10-12 1988-03-08 Bcm Technologies Antiestrogen therapy for symptoms of estrogen deficiency
WO1993023374A1 (fr) * 1992-05-08 1993-11-25 Otsuka Pharmaceutical Factory, Inc. Derive d'indole
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
GB9326332D0 (en) * 1993-12-23 1994-02-23 Karo Bio Indole derivatives
DE4426625A1 (de) * 1994-07-27 1996-03-14 Schering Ag 2-Phenylindole, Verfahren zu deren Herstellung, diese enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln
TW397821B (en) * 1996-04-19 2000-07-11 American Home Produits Corp 3-[4-(2-phenyl-indole-1-ylmethyl)-phenyl]-acrylamides and 2-phenyl-1-[4-(amino-1-yl-alk-1-ynyl)-benzyl]-1H-indol-5-ol as well as pharmaceutical compositions of estrogenic agents thereof
SK281737B6 (sk) * 1996-04-19 2001-07-10 American Home Products Corporation 2-fenylindolové zlúčeniny, farmaceutický prostriedok s ich obsahom a ich použitie
BR9710230A (pt) * 1996-07-09 1999-08-10 Smithkline Beecham Spa Derivados de indol para o tratamento de osteoporose
US5672609A (en) * 1996-07-18 1997-09-30 Eli Lilly And Company Pyridine compounds, intermediates compositions and methods of use
PT1025077E (pt) * 1997-10-15 2007-05-31 Wyeth Corp Novas ariloxi-alquil-dialquilaminas
AU1197299A (en) * 1997-10-28 1999-05-17 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
UA68365C2 (en) * 1997-11-06 2004-08-16 Wyeth Corp Peroral contraception by combination of anti-estrogen and progestin
AP1424A (en) * 1998-05-15 2005-06-06 Wyeth Corp 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens.

Also Published As

Publication number Publication date
SI1076558T1 (en) 2003-10-31
CZ299334B6 (cs) 2008-06-25
HRP20000778A2 (en) 2001-06-30
NO2015015I1 (no) 2015-06-02
AP1424A (en) 2005-06-06
KR20010043641A (ko) 2001-05-25
DE69909616T2 (de) 2004-06-17
JP2002515431A (ja) 2002-05-28
BR9911040A (pt) 2001-02-13
HK1031691A1 (en) 2001-06-22
HUP0103096A2 (hu) 2002-05-29
FR15C0035I1 (enExample) 2015-06-26
NO20005770D0 (no) 2000-11-14
EA005932B1 (ru) 2005-08-25
HUS1500023I1 (hu) 2017-03-28
IL139130A (en) 2005-11-20
SK284666B6 (sk) 2005-08-04
CN1326347A (zh) 2001-12-12
EE200000652A (et) 2002-04-15
TR200003377T2 (tr) 2001-03-21
EE04262B1 (et) 2004-04-15
HU226587B1 (en) 2009-04-28
JP2014159472A (ja) 2014-09-04
JP2009019042A (ja) 2009-01-29
PL194750B1 (pl) 2007-06-29
EA200001193A1 (ru) 2001-12-24
PL345268A1 (en) 2001-12-03
AU3894499A (en) 1999-12-06
AU760378B2 (en) 2003-05-15
LU92699I2 (fr) 2015-06-24
CZ20004254A3 (cs) 2001-12-12
PT1076558E (pt) 2003-11-28
ID26890A (id) 2001-02-15
NO328129B1 (no) 2009-12-14
OA11552A (en) 2004-06-07
JP5607871B2 (ja) 2014-10-15
ATE245026T1 (de) 2003-08-15
LTC1076558I2 (lt) 2016-11-10
IL139130A0 (en) 2001-11-25
DK1076558T3 (da) 2003-11-03
BG104930A (en) 2001-07-31
AR020074A1 (es) 2002-04-10
FR15C0035I2 (fr) 2015-08-28
CY2015020I1 (el) 2020-05-29
GEP20033079B (en) 2003-10-27
HRP20000778B1 (en) 2004-10-31
KR100620772B1 (ko) 2006-09-13
ZA200006959B (en) 2001-11-27
BE2015C026I2 (en) 2018-08-24
CU23241B7 (es) 2007-10-17
DE69909616D1 (de) 2003-08-21
UA66861C2 (uk) 2004-06-15
HUP0103096A3 (en) 2002-11-28
SK17202000A3 (sk) 2001-07-10
NO20005770L (no) 2001-01-12
EP1076558A1 (en) 2001-02-21
EP1076558B1 (en) 2003-07-16
JP5872624B2 (ja) 2016-03-01
NZ508200A (en) 2003-09-26
CN1230163C (zh) 2005-12-07
WO1999059581A1 (en) 1999-11-25
BG64783B1 (bg) 2006-04-28
ES2203131T3 (es) 2004-04-01
TW565554B (en) 2003-12-11
NO2015015I2 (no) 2015-06-02
CA2329530A1 (en) 1999-11-25
AP2000001970A0 (en) 2000-12-31

Similar Documents

Publication Publication Date Title
BE2014C048I2 (enExample)
BE2012C041I2 (enExample)
JP2001510969A5 (enExample)
BE2009C051I2 (enExample)
FR15C0035I1 (enExample)
BRPI9917862A2 (enExample)
JP2559520C (enExample)
JP2515524Z (enExample)
JP2514262Z (enExample)
IN190645B (enExample)
JP2530502Z (enExample)
JP2600054C (enExample)
CN3073771S (enExample)
CN3079173S (enExample)
CN3077998S (enExample)
BY4408C1 (enExample)
CN3079025S (enExample)
CN3073964S (enExample)
CN3079458S (enExample)
CN3076212S (enExample)
CN3072760S (enExample)
CN3079181S (enExample)
CN3076811S (enExample)
CN3074692S (enExample)
CN3074474S (enExample)